Current perspectives on radiation-induced breast cancer

Area of Science:

• Oncology
• Radiology
• Genetics

Background:

• Radiation exposure, particularly from atomic bomb radiation, occupational sources, and therapeutic treatments like Hodgkin's disease (HD), is linked to an increased risk of breast cancer.
• Understanding risk factors is crucial for developing effective screening and prevention strategies for radiation-induced breast cancer.

Purpose of the Study:

• To offer an approach for the screening and detection of radiation-induced breast cancer.
• To suggest primary and secondary prevention strategies for radiation-induced breast cancer.
• To emphasize the necessity of prospective clinical trials for evaluating screening efficacy.

Main Methods:

• A review of published evidence on radiation-induced breast cancer from various exposure types (atomic bomb, occupational, therapeutic).
• Examination of preclinical studies to identify potential risk factors.
• Analysis of genetic factors, including BRCA1, BRCA2, p53, and ataxia telangiectasia (AT) genes, and DNA repair proficiency.

Main Results:

• Breast tissue differentiation, influenced by age and hormones, is a key risk factor in radiation-induced breast cancer.
• Genetic predispositions, such as mutations in BRCA1/BRCA2, p53, and AT genes, and impaired DNA repair, are associated with increased risk.
• Primary prevention strategies include minimizing radiation exposure, genetic screening, and hormonal modulation. Secondary prevention may involve tamoxifen, dietary changes, and flaxseed consumption.

Conclusions:

• For patients irradiated before age 30 for Hodgkin's disease, recommendations include monthly breast self-examination (BSE), annual mammography starting 8 years post-irradiation, and biannual physical exams.
• A strong recommendation for a prospective randomized trial to compare different surveillance intensities for radiation-induced breast cancer screening efficacy.